0.15
0.66%
-0.001
Handel nachbörslich:
.16
0.01
+6.67%
Finanzdaten der Viracta Therapeutics Inc-Aktie (VIRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
2.32%
13.88
|
13.56 | 12.47 | 12.45 | 12.21 |
Interest Income/Expense |
9.59%
0.858
|
0.949 | 0.953 | 0.921 | 0.88 |
Operating Income/Loss |
2.32%
-13.88
|
-13.56 | -12.47 | -12.45 | -12.21 |
Income/Loss From Continuing Operations Before Tax |
33.59%
-9.141
|
-13.77 | -12.60 | -12.48 | -12.21 |
Income/Loss From Continuing Operations After Tax |
33.59%
-9.141
|
-13.77 | -12.60 | -12.48 | -12.21 |
Net Income/Loss
|
33.59%
-9.141
|
-13.77 | -12.60 | -12.48 | -12.21 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
70,188%
39.32
|
0.0559 | 38.68 | 38.56 | 38.46 |
Diluted Average Shares |
70,188%
39.32
|
0.0559 | 38.68 | 38.56 | 38.46 |
Basic Earnings Per Share |
34.29%
-0.23
|
-0.35 | -0.33 | -0.32 | -0.32 |
Diluted Earnings Per Share |
34.29%
-0.23
|
-0.35 | -0.33 | -0.32 | -0.32 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):